Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Obstetrics

The Biology of Placental Insufficiency: Why It Happens

At a Glance

Placental insufficiency is a biological issue where uterine blood vessels fail to widen properly, limiting oxygen and nutrients to the baby. It is not your fault and is often linked to conditions like preeclampsia. Low-dose aspirin may help prevent it in future pregnancies.

It is common for parents to feel a sense of guilt when they hear their baby isn’t growing well, but it is important to know that placental insufficiency is a biological and structural event, not a reflection of anything you did or didn’t do [1]. At its core, this is a “plumbing” and “supply” issue within the placenta that begins very early in pregnancy [2][3].

The Biology of the “Supply Line”

In a typical pregnancy, the mother’s blood vessels in the uterus (called spiral arteries) undergo a major renovation. They transform from narrow, high-pressure tubes into wide, high-capacity channels to send a steady stream of blood to the baby [3][4].

In placental insufficiency, this “remodeling” doesn’t happen correctly:

  • Failed Remodeling: The spiral arteries remain narrow and tight. This limits the amount of oxygen and nutrients that can reach the placenta [3][4].
  • Impaired Angiogenesis: This is a fancy word for the growth of new blood vessels. In a struggling placenta, the balance of growth factors is off, meaning the placenta cannot grow the complex web of vessels it needs to support the baby [5][6].
  • Oxidative Stress: Because the blood flow is restricted and irregular, it creates a “stress” environment within the placental tissue. This can cause damage to the cells that are supposed to be transferring nutrients to your baby [7][8].

How Maternal Conditions Play a Role

Certain health conditions can make it harder for the placenta to form that healthy “supply line.”

  • Preeclampsia and Hypertension: High blood pressure can damage the delicate vessels of the placenta or prevent them from opening up properly in the first place [9][10].
  • Autoimmune Disorders: Conditions like Systemic Lupus Erythematosus (SLE) or Antiphospholipid Syndrome (APS) can cause the immune system to interfere with how the placenta attaches and grows. In APS, antibodies can even cause tiny clots that block blood flow to the baby [11][12].

Modern Tools: The sFlt-1/PlGF Ratio

Doctors now have a specialized blood test that acts like a “stress thermometer” for the placenta by measuring the ratio between two proteins: sFlt-1 (which can block vessel growth) and PlGF (which promotes it) [13][14].

Note: This test is primarily FDA-approved in the U.S. for hospitalized patients showing signs of severe preeclampsia, to predict if their condition will worsen [15][16]. It is not a standard screening tool for all cases of isolated growth restriction, and its availability varies widely by hospital.

Looking Forward: Low-Dose Aspirin

If you have experienced placental insufficiency, you may wonder about future pregnancies. Current medical guidelines strongly recommend low-dose aspirin (81 mg) for people at high risk of preeclampsia [17][18].

  • How it Works: Aspirin helps the spiral arteries remodel correctly and reduces the inflammation that can lead to preeclampsia [19][20].
  • Expectations: Aspirin is highly proven to reduce the risk of preeclampsia-related growth issues [17]. However, if your placental insufficiency was isolated (not related to high blood pressure), the evidence is more mixed. It may not prevent all types of recurrent growth restriction [17].
  • Timing is Key: To be most effective, aspirin should be started between 12 and 16 weeks of pregnancy [20][21].

Common questions in this guide

Is placental insufficiency my fault?
No. Placental insufficiency is a biological and structural issue that begins early in pregnancy, usually related to how maternal blood vessels develop. It is a physical "plumbing" problem and is not caused by anything you did or didn't do.
Why does placental insufficiency happen?
The primary cause is the failed remodeling of the spiral arteries in the uterus. Instead of expanding into wide channels to deliver a high volume of blood, these vessels remain narrow, severely restricting the oxygen and nutrients that reach the baby.
Can high blood pressure cause placental insufficiency?
Yes. High blood pressure and preeclampsia can damage the delicate blood vessels of the placenta or prevent them from developing properly in the first trimester, directly interfering with the baby's supply line.
How do autoimmune conditions affect the placenta?
Autoimmune disorders like Systemic Lupus Erythematosus (SLE) or Antiphospholipid Syndrome (APS) can prompt the immune system to interfere with placental growth. In APS, antibodies can even create tiny blood clots that block essential blood flow to the baby.
What is the sFlt-1/PlGF ratio test?
This is a specialized blood test that measures the ratio between two proteins to gauge placental stress. It is primarily used in hospitalized patients showing signs of severe preeclampsia to predict if their condition is likely to worsen rapidly.
Can taking aspirin prevent placental insufficiency?
Current medical guidelines often recommend starting low-dose (81 mg) aspirin between 12 and 16 weeks of pregnancy. Aspirin helps blood vessels develop correctly and significantly reduces the risk of placental issues related to preeclampsia.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my placental pathology report show signs of spiral artery issues or maternal vascular malperfusion (MVM)?
  2. 2.Based on my history, should we use the sFlt-1/PlGF ratio to monitor my risk level in this or future pregnancies, or is it not indicated for my case?
  3. 3.If I take low-dose aspirin for my next pregnancy, should I start exactly at 12 weeks, and is 81 mg sufficient for my specific risk factors?
  4. 4.How do my specific conditions (like high blood pressure or an autoimmune disorder) change the way my placenta develops?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Relative uteroplacental insufficiency of labor.

    Ghi T, Fieni S, Ramirez Zegarra R, et al.

    Acta obstetricia et gynecologica Scandinavica 2024; (103(10)):1910-1918 doi:10.1111/aogs.14937.

    PMID: 39107951
  2. 2

    Fetal Growth Restriction: ACOG Practice Bulletin, Number 227.

    Obstetrics and gynecology 2021; (137(2)):e16-e28 doi:10.1097/AOG.0000000000004251.

    PMID: 33481528
  3. 3

    Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat.

    Barrientos G, Pussetto M, Rose M, et al.

    Molecular human reproduction 2017; (23(7)):509-519 doi:10.1093/molehr/gax024.

    PMID: 28402512
  4. 4

    Estrogen Actions in Placental Vascular Morphogenesis and Spiral Artery Remodeling: A Comparative View between Humans and Mice.

    Rusidzé M, Gargaros A, Fébrissy C, et al.

    Cells 2023; (12(4)) doi:10.3390/cells12040620.

    PMID: 36831287
  5. 5

    Clinical use of angiogenesis biomarkers in fetal growth restriction: a narrative review.

    Villalaín C, Galindo A, D'Antonio F, Herraiz I

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2025; (38(1)):2589630 doi:10.1080/14767058.2025.2589630.

    PMID: 41276305
  6. 6

    HIF-2α / HILPDA promotes ferroptosis sensitivity in placenta trophoblast cells of early-onset preeclampsia.

    Wang Q, Yang N, Chen H, et al.

    Placenta 2026; (174()):126-137 doi:10.1016/j.placenta.2025.12.009.

    PMID: 41422655
  7. 7

    Hyperglycemia-induced α-Klotho downregulation impairs mitophagy and promotes placental dysfunction in T2DM pregnancies.

    Niu J, Han B, Wang S, et al.

    Placenta 2025; (167()):95-103 doi:10.1016/j.placenta.2025.04.024.

    PMID: 40349475
  8. 8

    Hypoxia and Mitochondrial Dysfunction in Pregnancy Complications.

    Hu XQ, Zhang L

    Antioxidants (Basel, Switzerland) 2021; (10(3)) doi:10.3390/antiox10030405.

    PMID: 33800426
  9. 9

    Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway.

    Dupont V, Berg AH, Yamashita M, et al.

    The Journal of clinical investigation 2022; (132(20)).

    PMID: 35943814
  10. 10

    Diagnosis of placental insufficiency independently of clinical presentations using sFlt-1/PLGF ratio, including SGA patients.

    Kwiatkowski S, Bednarek-Jędrzejek M, Kwiatkowska E, et al.

    Pregnancy hypertension 2021; (25()):244-248 doi:10.1016/j.preghy.2021.07.245.

    PMID: 34315130
  11. 11

    Immunohistochemical analysis reveals higher Myxovirus resistance protein 1 expression and increased macrophage count in placentas from patients with systemic rheumatic diseases.

    Fierro JJ, Schoots MH, Liefers SC, et al.

    Rheumatology international 2025; (45(4)):90 doi:10.1007/s00296-025-05856-w.

    PMID: 40183958
  12. 12

    Antiphospholipid syndrome in pregnancy: a comprehensive literature review.

    Murvai VR, Galiș R, Panaitescu A, et al.

    BMC pregnancy and childbirth 2025; (25(1)):337 doi:10.1186/s12884-025-07471-w.

    PMID: 40128683
  13. 13

    Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?

    Alhudhud M, Yousuf H, Aljohani H, et al.

    Hypertension in pregnancy 2024; (43(1)):2434477 doi:10.1080/10641955.2024.2434477.

    PMID: 39620630
  14. 14

    Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction.

    Hong J, Kumar S

    Clinical science (London, England : 1979) 2023; (137(8)):579-595 doi:10.1042/CS20220300.

    PMID: 37075762
  15. 15

    Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

    Zeisler H, Llurba E, Chantraine F, et al.

    The New England journal of medicine 2016; (374(1)):13-22 doi:10.1056/NEJMoa1414838.

    PMID: 26735990
  16. 16

    Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.

    Ohkuchi A, Saito S, Yamamoto T, et al.

    Hypertension research : official journal of the Japanese Society of Hypertension 2021; (44(7)):813-821 doi:10.1038/s41440-021-00629-x.

    PMID: 33727707
  17. 17

    Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.

    , Davidson KW, Barry MJ, et al.

    JAMA 2021; (326(12)):1186-1191 doi:10.1001/jama.2021.14781.

    PMID: 34581729
  18. 18

    Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia.

    Zhou MK, Combs CA, Pandipati S, Del Rosario A

    American journal of obstetrics and gynecology 2023; (228(3)):349-351.e2 doi:10.1016/j.ajog.2022.11.1302.

    PMID: 36462540
  19. 19

    Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

    Henderson JT, Vesco KK, Senger CA, et al.

    JAMA 2021; (326(12)):1192-1206 doi:10.1001/jama.2021.8551.

    PMID: 34581730
  20. 20

    Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis.

    Choi YJ, Shin S

    American journal of preventive medicine 2021; (61(1)):e31-e45 doi:10.1016/j.amepre.2021.01.032.

    PMID: 33795180
  21. 21

    The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs.

    Yip KC, Luo Z, Huang X, et al.

    Archives of gynecology and obstetrics 2022; (305(6)):1465-1479 doi:10.1007/s00404-021-06349-4.

    PMID: 34999942

This page explains the biology of placental insufficiency for educational purposes only. Always consult your obstetrician or maternal-fetal medicine specialist regarding your pregnancy, ultrasound results, and preventative care plans.

Get notified when new evidence is published on Placental insufficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.